Reports by Industry

Pharmaceuticals Market Reports

Global Medical Silicone Sheet Market Size, Trends & Analysis - Forecasts to 2026 By Application (Surgical Wounds, Scar Patch, Burn Treatment), By End-User (Hospital & clinic, Ambulatory Surgical Center, Homecare), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

The rise in the number of accidents leading to chronic wounds and their lifelong psychological impact on the patients has instigated demand for sustainable wound care products. The medical silicone sheet is among the most promising product in the field of wound and scar management. Read More »
July 30 : 2021

Global Psoriasis Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Treatment Type (Topicals, Systemic, Biologics), By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors, Anti-Inflammatory, Corticosteroids, Vitamin D Analogues), By Application (Plaque Psoriasis, Guttate Psoriasis, Nail Psoriasis, Erythrodermic Psoriasis, Pustular Psoriasis, Intertriginous Psoriasis, Others), By Distribution Channel (Hospitals & Clinics, E-commerce, Retail Pharmacies), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global psoriasis drugs market is estimated to be valued at USD 19.30 billion in 2021 and is projected to reach USD 30.38 billion by 2026 at a CAGR of 9.5%. Rising disease consciousness, a boost in biologic reimbursement schemes, and sophisticated diagnostic and technological techniques are all plausible to drive up the use of psoriasis therapeutics. Read More »
July 28 : 2021

Global Pharmacovigilance Outsourcing Market Size, Trends & Analysis - Forecasts to 2028 By Type (Adverse Drug Reaction Capture (ADR), Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, and Enabling Architecture), By Service Provider (Contract Research Organization and Business Processing Outsourcing), By End User (Pharmaceutical Industry, Research Organization, and Others), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis

The global pharmacovigilance outsourcing market is projected to grow from USD 4.2 billion in 2021 to USD 10.9 billion by 2026 at a CAGR value of 16.7%. Pharmacovigilance or drug safety is a field of pharmacology that involves the collection, identification, and observation of the harmful side effects of pharmaceutical drugs. Read More »
July 22 : 2021

Global Systemic Lupus Erythematosus Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs, Immunosuppressants, Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, BLyS-specific Inhibitors or Monoclonal Antibodies, Anticoagulants, Biologics, Others), By Route of Administration (Oral, Intravenous, Subcutaneous), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The systemic lupus erythematosus market is estimated to be valued at USD 3.30 Billion in 2021 and is projected to reach USD 4.67 Billion by 2026 at a CAGR of 7.2%. The core drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, the growing need for targeted treatment, soaring levels of inflammatory diseases, increasing therapeutic interventions, and the emergence of biologics. Read More »
July 21 : 2021

Global Rheumatoid Arthritis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Biologics, Non-Biologics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Synthetic Disease-Modifying Antirheumatic Drugs, Other), Sales Channel (Prescription, OTC), By Route of Administration (Oral, Parenteral), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global rheumatoid arthritis therapeutics market is estimated to be valued at USD 25.66 billion in 2021 and is projected to reach USD 32.44 billion by 2026 at a CAGR of 4.8%. The key drivers which contribute to the market expansion include the increasing prevalence of chronic diseases, growing joint deformities, soaring need for advanced treatment solutions, growing inflammatory diseases, increasing emergence of biologics, a growing proportion of individuals suffering from autoimmune disorders, mounting demand & desire for novel therapeutics, continually evolving medical facilities, growing geriatric population, increasing technological advancements, expanding government initiatives, rising legal governance alignment, and increasing research and development. Read More »
July 16 : 2021

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global local anesthesia drugs market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. The core drivers which contribute to the market expansion include the increasing volume of surgeries related to chronic diseases, cardiovascular, accidents, cancer, nervous disorders and even getting relief from post-surgery. Read More »
July 15 : 2021

Global Urinary Incontinence Market Size, Trends & Analysis - Forecasts to 2026 By Type (Stress, Urge, Overflow, Functional, and Others), By Product (Urinary Catheters [Foley, Suprapubic, Intermittent], Urethral Slings [Male, Female], Electrical Stimulation Devices [Non-implantable, Implantable], Artificial Urinary Sphincters, Neuromodulation Devices, and Others), By Category (External and Internal), By End-User (Hospitals, Specialty Clinics, and Others); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis; By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The urinary incontinence market is estimated to be valued at USD 3.26 billion in 2021 and is projected to reach USD 4.67 billion by 2026 at a CAGR of 7.89%. The expansion of overall urinary incontinence market size is due to, an aging demographic with an elevated danger of urological illnesses, and an increment in urinary incontinent patient populations switching from mainstream treatment options to sophisticated surgical therapies. Read More »
July 6 : 2021

Global Cosmetics Market Size, Trends, and Analysis- Forecasts to 2026 By Application (Skin Care, Hair Care, Nail Care, Color Cosmetics, Deodorants, and Fragrances), By Distribution Channel (Retail Sales, Departmental Stores, Supermarket, Drug Store, Brand Outlets, Online Sales, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Global Cosmetics Market is estimated to be valued at USD 380.2 Billion in 2021 to USD 465.0 Billion by 2026 with a CAGR value of 5.5% from 2021 to 2026. With the flourishing fashion and entertainment industry, the demand for latest cosmetics is increasing significantly. Read More »
June 15 : 2021

Global Fatty Acid Oxidation Disorder Market Size, Trends, and Analysis - Forecasts To 2026 By Drug Type (Levocarnitine, Dextrose, Riboflavin, and Others), By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Stores), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The overall population is expected to reach 8.5 billion by 2030, leading to an increase in the worldwide consumption of numerous products. Expanding need for sustainable bio-products including soaps, food emulsifiers, surface cleaners, detergents, fertilizers, cosmetics, paints, and skincare items has raised the fatty acid market requirement for industrial commercial, and consumer use. Read More »
June 9 : 2021

Global Bipolar Disorder Market Size, Trends & Analysis - Forecasts to 2026 By Mechanism of Action (Benzodiazepines, Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Tricyclic antidepressant drugs, Monoamine oxidase inhibitors, Beta-blockers, Others) By Drug Class (Antidepressant drugs, Mood stabilizer, Anticonvulsants, Antianxiety drugs, Antipsychotic drugs) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

In the projected period, technological developments and the acceptance of a sedentary lifestyle are anticipated to propel the growth of the bipolar disorder treatment market. Also, expanding factors such as genetics and the environment may affect brain structure and chemistry, leading to the development of bipolar illnesses, which would enhance numerous prospects, resulting in the growth of the bipolar disorder treatment market over the projection period. Read More »
June 4 : 2021